RecruitingNot Applicable

Anxiolytic Effect of Virtual Reality Immersion Versus Midazolam Premedication in Patients Undergoing Dacryocystorhinostomy Surgery

Egypt40 participantsStarted 2025-06-01

Plain-language summary

The aim is to investigate the anxiolytic effect, and hemodynamic stability of using virtual reality immersion in adult patients undergoing Dacryocystorhinostomy (DCR) operation under general anesthesia and to compare its effect to that of using Midazolam as a premedication.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Aged 18-65. * Both sexes. * American Society of Anesthesiologists (ASA) classification: I - II. * Patient undergoing Dacryocystorhinostomy Surgery (DCR) operation under general anesthesia. Exclusion Criteria: * Patient refusal. * Patients with cardiac diseases. * Patients with renal diseases. * Patients with drug sensitivity and seizures. * Substance abuse and addiction. * Claustrophobia. * Patients with cerebrovascular disease. * Psychiatric and cognitive disorder. * Patients with severe teary eyes and blurring of vision. * Patients who express discomfort during the test.

What they're measuring

Anxiety Score

Timeframe: 15-minute after intervention

Trial details

NCT IDNCT07050095

SponsorCairo University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-12-30

Contact for this trial

Hebatullah S Abdelhamid, MD

002 01044512277 drhebasalah593@gmail.com

View on ClinicalTrials.gov More Anxiolytic Effect trials